Trials / Unknown
UnknownNCT03510832
Evaluation of Antithrombotic STrategies in STEMI Patients in China
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 8,000 (estimated)
- Sponsor
- Qilu Hospital of Shandong University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
EAST-STEMI is the first perspective, multicenter, large-scale registry focusing on the evaluation of real-world medical quality (especially PCI quality) and antithrombotic strategies in STEMI patients undergoing emergent PCI in a regional representative sample in China with 2 years follow-up. Clinical decision support tools (including ischemic score, bleeding score, etc) will be developed and validated based on the database. Novel biomarkers to predict the prognosis and to support risk stratification will be explored by using the blood samples.
Conditions
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2021-06-30
- Completion
- 2021-12-31
- First posted
- 2018-04-27
- Last updated
- 2018-04-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03510832. Inclusion in this directory is not an endorsement.